07.01.03
Indication: Menopause symptoms
Source: Obstetrics and Gynecology, 2003;101:1213-1220.
Research: A randomized, placebo-controlled crossover trial studied phytoestrogens in treatment of menopause in breast cancer patients. Fifty-six women who had been treated for breast cancer were randomly assigned to the phytoestrogen group or the placebo group. At three months both groups received no therapy and then switched treatments for the next three months. Subject were interviewed throughout the study with regard to menopausal symptoms, including hot flashes.
Results: Researchers concluded that pure isoflavonoids were not effective in alleviating subjective menopausal symptoms or improving quality of life in breast cancer patients. The only difference between the two groups was in the acceptance of the pills. Approximately 45% of the women preferred the phytoestrogen regimen, while 27% preferred the placebo.
Source: Obstetrics and Gynecology, 2003;101:1213-1220.
Research: A randomized, placebo-controlled crossover trial studied phytoestrogens in treatment of menopause in breast cancer patients. Fifty-six women who had been treated for breast cancer were randomly assigned to the phytoestrogen group or the placebo group. At three months both groups received no therapy and then switched treatments for the next three months. Subject were interviewed throughout the study with regard to menopausal symptoms, including hot flashes.
Results: Researchers concluded that pure isoflavonoids were not effective in alleviating subjective menopausal symptoms or improving quality of life in breast cancer patients. The only difference between the two groups was in the acceptance of the pills. Approximately 45% of the women preferred the phytoestrogen regimen, while 27% preferred the placebo.